Do you find the pCR improvement with neoadjuvant ultra-hypofractionated RT in NeoORB compelling enough to start considering sequencing radiation before surgery in selected breast cancer patients?
This question is part of our ASTRO 2026 collaboration, inspired by the LBA Session Presentation "Neoadjuvant Radiotherapy in Breast Cancer: A Study on the Optimal Sequencing of Radiation in Breast Cancer (NEOORB)" by Dr. Rishi Nair, MBBS
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · Harvard Medical School
Answered on
Adjuvant radiation remains the standard of care in breast cancer; however, the concept of pre-operative or neoadjuvant radiation (NART) has held durable appeal for both early-stage and locally advanced breast cancer due to several potential advantages. First, it allows for treatment to intact anatom...
Join for free or sign in to see the full answer
Mednet Member
Radiation Oncology · UNC Hospitals- N.C. Cancer Hospital
Answered on
The NeoORB findings are intriguing and reassuring in that preoperative ultra-hypofractionated radiotherapy appears feasible and is associated with substantial increases in both breast and nodal pathologic complete response. However, I would view these results as requiring further investigation befor...
Join for free or sign in to see the full answer